Disease Progression:
Various factors
that influence HCV disease progression including steatosis, obesity, insulin
resistance, diabetes, race/ethnicity, and general studies on disease
progression.
·
Diabetes
o
505. High RNA HCV as Associated
Factor to Hyperglycemia in Hepatitis C Chronic Patients.
·
Extrahepatic Manifestations
o
1066. Is HOMA-IR the best marker of insulin
resistance in chronic hepatitis due to HCV infection?
o
1075. Hepatitis C virus infection enhances insulin
resistance induced by visceral fat accumulation.
o
1941. Marginal zone lymphoma and HCV
infection: role of antiviral treatment.
·
General
o
358. Fulminant hepatic failure associated with chewing
khat.
o
369. Assessing Hepatotoxicity of Thiazolidinediones
(TZDs), Metformin, and/or Statin Therapy in Chronic Hepatitis C (HCV) Patients.
(Updated Nov 1)
o
470. The Impact Of Alcohol Abuse, HCV Infection And Liver Dysfunction On
Neuropsychological And Neurophysiological Profile Of Patients With Liver
Cirrhosis. (Updated Nov 1)
o
504. The Illness Intrusiveness of a Hepatitis C
Diagnosis.
o
1057. Natural history of HCV superinfection and
reinfection.
o
1062. Hepatitis C as a risk factor for primary renal
cell carcinoma.
o
1935. Prevalence and Predictors of Liver
Fibrosis in Hepatitis C (HCV) Infected Hemophilic Men.
·
Hepatocellular Carcinoma (
o
1087. Hepatitis C virus proteins can modulate
microRNA expression and chemotherapeutic responses in Hepatocellular Carcinoma
(HCC)
·
Race
o
1022. Severity of Liver Disease in Chronic Hepatitis
C Patients: Latino versus Caucasian.
o
1031. Differential Gene Expression between Caucasian
and African American Patients with Chronic Hepatitis C (CH-C).